Inhibitive effect of artemether on tumor growth and angiogenesis in the rat C6 orthotopic brain gliomas model
- PMID: 19174507
- DOI: 10.1177/1534735408330714
Inhibitive effect of artemether on tumor growth and angiogenesis in the rat C6 orthotopic brain gliomas model
Erratum in
- Integr Cancer Ther. 2009 Jun;8(2):195
Abstract
To explore the inhibitive effect of artemether on glioma growth and angiogenesis in brain tumor bearing SD rat. MTT assay was used to evaluate the inhibitory effect of artemether treatment on C6 glioma cells. Forty SD rats which were subcutaneous planted with SD rat C6 glioma cell to establish SD rat orthotopic glioma model were divided resourcefully into 5 groups. each group was 8 rats. Length-path (a mm) and short-path (b mm) of tumor each rat was measured. Tumor volume was calculated using the following formula: V (mm(3)) = a(2)bpi/6. Microvessel density (MVD) in different therapy groups was significantly lower than that in normal saline control group and brain glioma volume in different therapy groups was significantly smaller than that in normal saline control group. There were remarkably inhibitory effects of artmeter on brain glioma growth and angiogenesis in SD rats and the mechanism that artemether inhibited brain glioma growth might be penetrating the blood-brain barrier and inhibiting angiogenesis.
Similar articles
-
Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.Mol Pharm. 2009 May-Jun;6(3):905-17. doi: 10.1021/mp800218q. Mol Pharm. 2009. PMID: 19344115
-
Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.Exp Neurol. 2000 Jan;161(1):234-44. doi: 10.1006/exnr.1999.7247. Exp Neurol. 2000. PMID: 10683290
-
Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo study.NMR Biomed. 2008 Nov;21(10):1043-56. doi: 10.1002/nbm.1278. NMR Biomed. 2008. PMID: 18615861
-
Angiogenesis in malignant glioma--a target for antitumor therapy?Crit Rev Oncol Hematol. 2006 Sep;59(3):181-93. doi: 10.1016/j.critrevonc.2006.01.004. Epub 2006 Jul 24. Crit Rev Oncol Hematol. 2006. PMID: 16860996 Review.
-
Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.J Clin Neurosci. 2009 Sep;16(9):1119-30. doi: 10.1016/j.jocn.2009.02.009. Epub 2009 Jun 24. J Clin Neurosci. 2009. PMID: 19556134 Review.
Cited by
-
Enhancement of Anticancer Potential of Artemisinin Derivatives through N-glycosylation.Curr Top Med Chem. 2024;24(23):2074-2091. doi: 10.2174/0115680266322676240724114536. Curr Top Med Chem. 2024. PMID: 39136507 Review.
-
Expression level comparison of marker genes related to early embryonic development and tumor growth.Oncol Lett. 2022 Oct 26;24(6):444. doi: 10.3892/ol.2022.13564. eCollection 2022 Dec. Oncol Lett. 2022. PMID: 36420077 Free PMC article.
-
Synthesis of Artemether-Loaded Albumin Nanoparticles and Measurement of Their Anti-Cancer Effects.Biomedicines. 2022 Oct 26;10(11):2713. doi: 10.3390/biomedicines10112713. Biomedicines. 2022. PMID: 36359230 Free PMC article.
-
Canagliflozin Inhibits Glioblastoma Growth and Proliferation by Activating AMPK.Cell Mol Neurobiol. 2023 Mar;43(2):879-892. doi: 10.1007/s10571-022-01221-8. Epub 2022 Apr 18. Cell Mol Neurobiol. 2023. PMID: 35435536
-
Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing.Pharmacol Ther. 2020 Dec;216:107706. doi: 10.1016/j.pharmthera.2020.107706. Epub 2020 Oct 16. Pharmacol Ther. 2020. PMID: 33075360 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
